AMANDA SING: Open Payments
NPI 1508485749 · JOHNS CREEK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 31 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Novo Nordisk Inc | 5 | $86 |
| Lilly USA, LLC | 3 | $62 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| ABBVIE INC. | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| SHIELD THERAPEUTICS INC | 2 | $31 |
| INTUITIVE SURGICAL, INC. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
Products named: AIRSUPRA, XIFAXAN, ZEPBOUND, LAGEVRIO, Wegovy, Rybelsus, ACCRUFER, QULIPTA.
Industry payments across GA — which companies pay providers there.
